Details for Patent: 7,820,788
✉ Email this page to a colleague
Which drugs does patent 7,820,788 protect, and when does it expire?
Patent 7,820,788 protects ABRAXANE and is included in one NDA.
Protection for ABRAXANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-seven patent family members in twenty-one countries.
Summary for Patent: 7,820,788
Title: | Compositions and methods of delivery of pharmacological agents |
Abstract: | The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell. |
Inventor(s): | Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA), Trieu; Vuong (Calabasas, CA) |
Assignee: | Abraxis Bioscience, LLC (Los Angeles, CA) |
Application Number: | 11/553,339 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,820,788 |
Patent Claim Types: see list of patent claims | Composition; Use; Delivery; |
Drugs Protected by US Patent 7,820,788
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol-myers | ABRAXANE | paclitaxel | POWDER;INTRAVENOUS | 021660-001 | Jan 7, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,820,788
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003299590 | ⤷ Try a Trial | |||
Brazil | 0317134 | ⤷ Try a Trial | |||
Canada | 2509365 | ⤷ Try a Trial | |||
China | 102343094 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |